{"nct_id":"NCT03551626","title":"Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes","status":"COMPLETED","status_verified_date":"2025-04","start_date":"2018-08-29","start_date_type":"ACTUAL","primary_completion_date":"2020-10-05","primary_completion_date_type":"ACTUAL","completion_date":"2021-09-16","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}